Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 15,195 | 13,511 | 14,171 | 12,623 | 15,542 |
| Cost of Goods | 2,643 | 2,537 | 2,505 | 2,398 | 2,685 |
| Gross Profit | 12,552 | 10,974 | 11,666 | 10,225 | 12,857 |
| Operating Expenses | 12,315 | 12,348 | 12,444 | 12,416 | 13,157 |
| Operating Income | 237 | -1,374 | -778 | -2,191 | -300 |
| Interest Expense | 897 | 2,445 | 1,733 | 2,018 | 2,299 |
| Other Income | -1,322 | -116 | 12 | -250 | -339 |
| Pre-tax Income | -1,982 | -3,935 | -2,499 | -4,459 | -2,938 |
| Income Tax | -647 | -17 | 242 | -23 | 85 |
| Net Income Continuous | -1,335 | -3,918 | -2,741 | -4,436 | -3,023 |
| Net Income | $-1,335 | $-3,918 | $-2,741 | $-4,436 | $-3,023 |
| EPS Basic Total Ops | -0.04 | -0.12 | -0.09 | -0.14 | -0.10 |
| EPS Basic Continuous Ops | -0.04 | -0.12 | -0.09 | -0.14 | -0.10 |
| EPS Diluted Total Ops | -0.04 | -0.12 | -0.09 | -0.14 | -0.10 |
| EPS Diluted Continuous Ops | -0.04 | -0.12 | -0.09 | -0.14 | -0.10 |
| EBITDA(a) | $4,378 | $4,021 | $4,717 | $2,919 | $4,795 |